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Objective. Acute atrial ﬁbrillation often spontaneously resolves. This study aimed to investigate the outcomes and satisfaction of
an evidence-based ED protocol employing a “wait and see” approach. Methods. A prospective observational cohort study of adult
patients presenting to the Emergency Department with stable acute atrial ﬁbrillation was performed. Patients were excluded if they
were considered to be unstable, need hospitalization, or poor candidates for ED procedural sedation. Routine care was provided
on the index visit, and suitable candidates were discharged and asked to return to the ED the following day for possible electrical
cardioversion.Outcomemeasuresincludedspontaneousreversiontosinusrhythm,successofcardioversion,lengthofstay,adverse
event and return visits for AF within 30 days, and patient satisfaction. Results. Thirty ﬁve patient encounters were analysed over
a 21-month period. Twenty two of the 35 patients (63%) had spontaneous resolution of atrial ﬁbrillation upon presentation
for potential cardioversion. All of the remaining patients underwent successful cardioversion to normal sinus rhythm without
signiﬁcant adverse events recorded. No patients required hospitalization. Three patients (9%) returned to the ED within 30 days
for recurrence of atrial ﬁbrillation. All patients were reported to be “very satisﬁed” with this approach. Conclusion. A “wait and
see” approach to the ED electrical cardioversion of atrial ﬁbrillation showed that almost two-thirds of patients had spontaneous
resolution without requiring cardioversion or observation in the ED or hospital. All patients were successfully reverted to normal
sinus rhythm and had a high degree of satisfaction.
1.Introduction
Atrial ﬁbrillation (AF) is the most commonly encountered
arrhythmia in the Emergency Department (ED). There are
quite wide diﬀerences in the ED management of acute
AF [1–3]. Treatment primarily focuses on rate or rhythm
controlalongwithanticoagulationifnecessary.Traditionally,
many patients were hospitalized when found to be in
acute AF. More recent studies have demonstrated the safe
cardioversion of selected patients with acute AF in the
Emergency Department without requiring hospitalization
[4–8]. Others have shown the suitability for these patients
to be treated successfully in an observation unit [9, 10].
Well-regarded international guidelines allow for the
cardioversion of acute AF in selected patients within a 48-
hour window of opportunity before anticoagulation must be
instituted[11].However,thereisdebateastotheappropriate
strategy of rate or rhythm control for acute atrial ﬁbrillation
[12, 13]. Nevertheless, cardioversion of acute AF has become
an accepted practice in many Emergency Departments [2].
Numerous studies quite clearly demonstrate the supe-
riority of electrical cardioversion over pharmacologic car-
dioversion for obtaining sinus rhythm [1, 2, 4–7, 11].
Disadvantages of pharmacological attempts include pro-
arrhythmicsideeﬀectsofmedications,longertimeintheED,
and lower overall success rate. The primary disadvantage of
DC cardioversion relates to the procedural sedation.
The likelihood of spontaneous conversion of acute AF to
sinus rhythm is reported to be as high as 70% [14]. Although
active cardioversion of patients is generally considered to
be safe, one could reasonably question the strategy of
immediate treatment for a condition that is likely to resolve
spontaneously. In this age of access block and limited
resources, it is important to create protocols that maximize
existing resources and ensure patient safety.2 Emergency Medicine International
An evidence-based protocol was created at a single insti-
tution that allowed for the potential spontaneous resolution
of AF prior to active attempts at cardioversion. To the
best of our knowledge, this “wait and see” approach has
not been previously studied. The protocol allowed for the
early discharge of patients without prolonged observation or
admission to hospital. The study assessed the outcomes and
satisfaction of this protocol.
2. Methods
A prospective observational cohort study was undertaken
to investigate the outcomes and satisfaction of an evidence-
based protocol (Table 1) for the treatment of acute atrial ﬁb-
rillation. Formal approval was obtained from the Tasmanian
Human Research Ethics Network.
TheNorthWestRegionalHospitalinTasmania,Australia
is formally accredited for training in Emergency Medicine
and has an annual census of 25,000 visits. This study was
undertaken for a 21-month period from December 2008 to
August 2010.
Adult patients were approached for inclusion at the
discretion of the treating doctor if they were considered
to have stable acute AF and suitable for a rhythm control
strategy. Patients were excluded if they were considered to
be unstable, have severe symptoms, require hospitalization,
pregnant, or poor candidates for ED procedural sedation. It
wasrequiredthattheprotocolandpotentialcardioversionbe
completed within the safe 48-hour window of opportunity
for this procedure.
The protocol called for participants to be given usual
treatment for rate control and anticoagulation at the
discretion of the initial treating doctor. The lead study
investigator (BD) was contacted upon patient enrolment and
a standard data form was completed. The participants were
discharged and asked to return the following day to the ED
for potential electrical cardioversion. Institutional guidelines
f o rp r o c e d u r a ls e d a t i o nw e r ef o l l o w e d .A l lp r o c e d u r e sw e r e
conducted by Emergency Medicine specialists (Fellows of the
Australasian College of Emergency Medicine). The agent(s)
for procedural sedation and the energy level of each shock
were at the discretion of the treating doctor.
Data were initially collected regarding patient demo-
graphics and medications given in the Emergency Depart-
ment. Data collected on the second visit included the
agents of procedural sedation given, number of shocks
administered, and joules per shock. ED length of stay was
calculated.
Study outcomes included the proportion of patients
with spontaneous resolution of AF upon presentation for
potential cardioversion, the success of DC cardioversion, the
overall return to sinus rhythm, and the number of patients
returning to the ED within 30 days with a diagnosis of
atrial ﬁbrillation. Patient satisfaction was determined on
a ﬁve-point modiﬁed Likert scale conducted by telephone
interview at 7 days by the lead investigator. Prespeciﬁed
adverse events included oxygen desaturation less than 90%
during procedural sedation, aspiration, utilization of bag
Table 1: Emergency Department protocol for cardioversion of
atrial ﬁbrillation.
(i) Ensure patient has stable acute atrial ﬁbrillation
(ii) Exclusion criteria: unstable or severe symptoms, patient
requires hospitalization, >48-hour duration of AF by next day
cardioversion, poor candidate for ED procedural sedation, age
<18, or pregnancy
(iii) Patients may get rate control and other medications at the
discretion of treating doctor
(iv) Discharge patient to return to ED the following day at 08:00
for DC cardioversion. Advise patient to fast after midnight.
(v) Obtain ECG on day 2
(vi) If patient still in AF, conﬁrm inclusion & exclusion criteria
and proceed with DC cardioversion
valve mask, endotracheal intubation, apnoea greater than
30 seconds, and acute stroke. Other complications not
prospectively deﬁned were also sought.
Data were entered and analysed in to Microsoft Oﬃce
Excel 2003 for Windows (Microsoft Corporation, Seattle,
USA). Standard descriptive statistics were derived; ED
lengths of stay (EDLOS) were expressed as median and
interquartile range (IQR). Comparisons of EDLOS were
made using Wilcoxon signed-rank tests using Stata 10.0
(StataCorp, Tex, USA).
3. Results
During the study period, 256 patients were discharged or
admitted from the Emergency Department with a ﬁnal
diagnosis of atrial ﬁbrillation of any duration. Most of these
patients did not have acute AF and/or met other exclusion
criteria.Thirty-fouradultpatientsconsentedtoinclusionbut
one patient was withdrawn for meeting exclusion criteria.
Two patients were enrolled twice during the study period.
There were thirty-ﬁve evaluable datasets. The overall results
are summarized on Table 2.
Twenty-two (63%) patients had spontaneous resolution
of atrial ﬁbrillation discovered upon representation on day
2 and thus did not require electrical cardioversion. All
remaining patients underwent successful DC cardioversion.
All patients were discharged from the ED on day 2 in sinus
rhythm. Six patients returned to the ED within 30 days, of
whom 3 (9%) were found to be in atrial ﬁbrillation. The
median total ED length of stay combined for both visits was
177 (IQR 137–260) minutes. For those that spontaneously
reverted their median total time was 150 (IQR 105–193)
minutes and for those that required cardioversion 263
(IQR 221–304) minutes (P<0.001). No patients required
hospitalization. All patients (100%) were reported to be
“very satisﬁed” upon telephone followup at 7 days after
treatment
All procedural sedations were performed using propofol
with an average total dose of 1mg/kg. Median number of
shocks was 1 and ranged from 1–4.
T h e r ew e r en op r e s p e c i ﬁ e da d v e r s ee v e n t sr e p o r t e d .
Unstructured adverse events included one report of
“asymptomatic hypotension” during procedural sedation.Emergency Medicine International 3
Table 2: Demographics & ED Length of Stay.
Spontaneous reversion
(n = 22)
Not spontaneously reverted
(n = 13)
Gender (M:F) 14:8 9:4
Median age (IQR) in years 55 (44–66) 62 (51–63)
EDLOS day 1 in minutes (IQR) 124 (84–141) 151 (111–187)
EDLOS day 2 in minutes
(IQR) 24 (15–45) 96 (70–130)∗
EDLOS total in minutes (IQR) 150 (105–193) 263 (221–304)∗∗
∗P<0.000, ∗∗P<0.001.
One patient reported a “sore chest” during telephone inter-
view at day 7. There were no cases of stroke.
4. Discussion
Thetreatmentstrategyofacuteatrialﬁbrillationisnotclearly
deﬁned. Several randomized trials comparing rate to rhythm
control have not shown an advantage to rhythm control [15–
17]. However, there are several limitations to these studies.
Many enrolled older patients with more persistent atrial
ﬁbrillation. This may not be externally valid to a younger
patient with short onset of atrial ﬁbrillation that may present
to the Emergency Department.
There is a common saying “atrial ﬁbrillation begets atrial
ﬁbrillation” [11]. This implies that there is atrial remodelling
in response to AF that perpetuates the arrhythmia. Well-
regarded published guidelines conclude that there is a
window of opportunity to maintain sinus rhythm that
should not be overlooked early in the course of management
of AF. Rate control may be a reasonable option in older
patients with persistent AF, but for the younger patient,
especially those with paroxysmal lone AF, rhythm control
may be the better initial option. These guidelines state that
cardioversion can be safely performed without preceding
anticoagulation in suitable patients if AF is of less than 48-
hour duration [11].
The rate of spontaneous conversion of acute atrial
ﬁbrillation is high. A prospective study of spontaneous
conversion rates of acute AF (<72 hours duration) to
sinus rhythm showed almost a 70% conversion rate [14].
Patients with symptoms of less than 24 hours duration were
the best predictor of spontaneous conversion. Many other
studies looking at pharmacologic agents versus placebo for
cardioversion give us a clue as to the rate of spontaneous
conversion of atrial ﬁbrillation [18–21]. A randomized,
placebo controlled trial of amiodarone demonstrated a 64%
conversion rate within 24 hours in those that received
placebo [18]. A placebo controlled study of propafenone
versus digoxin plus quinidine showed a 76% conversion rate
in the placebo arm [19]. One might conclude that “placebo”
is quite eﬀective and safe for the treatment of acute atrial
ﬁbrillation.
If the spontaneous conversion rate of acute atrial ﬁbril-
lation is quite high, then one should seriously question a
strategy that involves early active treatment. This may expose
the patient to unnecessary procedures and medications,
potential complications, and unnecessarily utilize hospital
resources. Our study employed a “wait and see” approach
to allow for the spontaneous reversion of AF while the
patient was discharged home. Almost two-thirds of the
patients did not require active treatment with electrical
cardioversion. Total ED length of stay was short compared to
other published reports as described above, and all patients
were eventually discharged in sinus rhythm.
There are several limitations to this study. The number of
patients enrolled was small. This does not allow for detection
of less common complications. The success rate of 100% to
sinus rhythm is contrary to other published reports showing
rates closer to 90% for electrical cardioversion. The median
age of our study population was 57 compared to the average
age of patients with AF reported to be around 75 years of age.
This was not a trial of all patients with acute AF, and clearly
a younger and likely healthier population was selected.
This study was performed at a single site with motivated
investigators and external validity must be considered. All
proceduralsedation wasundertakenbyEmergencyMedicine
specialists and other outcomes might be observed utilizing
other groups. In general, ED length of stay tends to be
shorter in regional hospitals. A reported high degree of
patientsatisfactionmayrepresentsomebiasasthistelephone
interview was conducted by the lead investigator who may
have also been directly involved in their patient care.
The protocol did not specify which medications should
be given for rate control and/or anticoagulation. Three
patients received amiodarone and one patient sotolol which
may account for higher conversion rates.
T h e r ei sn op a t i e n tc h a r g ef o rp u b l i cE Dc a r ei nA u s -
tralia. Therefore external validity must be considered when
addressing satisfaction and compliance with this protocol in
other settings.
One might reasonably question a protocol requiring
patients to return to the ED for a scheduled elective
cardioversion. However, in this study admission to hospital
or observation unit was avoided. In addition, owing to the
natural history of acute AF, almost two-thirds of patients did
not require active cardioversion. Other institutions may have
o t h e rr e s o u r c e sa v a i l a b l et oa l l o wf o rad i ﬀerent approach.
Therefore, this study may not be applicable or feasible in
other departments. But it would be diﬃcult to imagine a
strategy at most hospitals that would use less resources,
decrease admissions, decrease ED length of stay, minimize4 Emergency Medicine International
procedures, all the while resulting in reversion to normal
sinus rhythm.
5. Summary
This study of a “wait and see” protocol for the ED cardiover-
sion of acute atrial ﬁbrillation demonstrated almost two-
thirds of patients had spontaneous resolution of AF prior
to active attempts at cardioversion. Total ED length of stay
was short, and all patients attained sinus rhythm. Patients
did not require admission to hospital or an observation
ward.Adverseevents wereminimal. A smallpercentage(9%)
returnedwithin30dayswitharecurrenceofAF.Thisstrategy
met with a high degree of patient satisfaction.
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